Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.98 INR | -4.14% | -4.14% | -25.88% |
Valuation
Fiscal Period: Maart | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 238.8 | 135.2 | 81.94 | 70.61 | 156.9 | 814 |
Enterprise Value (EV) 1 | 377.3 | 332.3 | 275 | 281.8 | 368.4 | 980.5 |
P/E ratio | 99.1 x | 58.5 x | 24.4 x | 93.4 x | 51 x | 247 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.73 x | 0.47 x | 0.33 x | 0.39 x | 0.68 x | 2.19 x |
EV / Revenue | 1.16 x | 1.16 x | 1.11 x | 1.55 x | 1.59 x | 2.64 x |
EV / EBITDA | 12.5 x | 8.87 x | 7.03 x | 8.21 x | 10.5 x | 24.2 x |
EV / FCF | -35.1 x | -5.03 x | -350 x | -10.1 x | -60.7 x | -24.9 x |
FCF Yield | -2.85% | -19.9% | -0.29% | -9.95% | -1.65% | -4.02% |
Price to Book | 2.36 x | 1.3 x | 0.77 x | 0.65 x | 1.41 x | 2.96 x |
Nbr of stocks (in thousands) | 4,820 | 4,820 | 4,820 | 4,820 | 4,820 | 8,920 |
Reference price 2 | 49.55 | 28.05 | 17.00 | 14.65 | 32.55 | 91.26 |
Announcement Date | 10/16/18 | 10/3/19 | 9/3/20 | 8/31/21 | 9/6/22 | 9/6/23 |
Income Statement Evolution (Annual data)
Fiscal Period: Maart | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 326.5 | 286.8 | 248.5 | 182.3 | 231.3 | 371.1 |
EBITDA 1 | 30.18 | 37.45 | 39.09 | 34.31 | 35.18 | 40.55 |
EBIT 1 | 15.34 | 23.49 | 24.16 | 16.23 | 18.84 | 22.33 |
Operating Margin | 4.7% | 8.19% | 9.72% | 8.9% | 8.15% | 6.02% |
Earnings before Tax (EBT) 1 | 4.841 | 2.413 | 4.56 | 1.085 | 3.723 | 4.173 |
Net income 1 | 2.422 | 2.312 | 3.357 | 0.7558 | 3.079 | 3.47 |
Net margin | 0.74% | 0.81% | 1.35% | 0.41% | 1.33% | 0.94% |
EPS 2 | 0.5000 | 0.4796 | 0.6965 | 0.1568 | 0.6388 | 0.3700 |
Free Cash Flow 1 | -10.75 | -66.12 | -0.7854 | -28.03 | -6.068 | -39.39 |
FCF margin | -3.29% | -23.05% | -0.32% | -15.37% | -2.62% | -10.62% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 10/16/18 | 10/3/19 | 9/3/20 | 8/31/21 | 9/6/22 | 9/6/23 |
Balance Sheet Analysis
Fiscal Period: Maart | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 138 | 197 | 193 | 211 | 212 | 166 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 4.587 x | 5.263 x | 4.939 x | 6.156 x | 6.012 x | 4.105 x |
Free Cash Flow 1 | -10.8 | -66.1 | -0.79 | -28 | -6.07 | -39.4 |
ROE (net income / shareholders' equity) | 2.42% | 2.25% | 3.19% | 0.7% | 2.82% | 2.15% |
ROA (Net income/ Total Assets) | 3.59% | 4.49% | 4% | 2.68% | 3.1% | 3.43% |
Assets 1 | 67.48 | 51.44 | 83.89 | 28.19 | 99.35 | 101 |
Book Value Per Share 2 | 21.00 | 21.50 | 22.20 | 22.40 | 23.00 | 30.80 |
Cash Flow per Share 2 | 0.4900 | 0.7100 | 1.760 | 0.2000 | 0.1700 | 0.1800 |
Capex 1 | 21.4 | 103 | 13.8 | 23.6 | 13 | 44.1 |
Capex / Sales | 6.55% | 36.03% | 5.54% | 12.92% | 5.63% | 11.87% |
Announcement Date | 10/16/18 | 10/3/19 | 9/3/20 | 8/31/21 | 9/6/22 | 9/6/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-25.88% | 6.02M | |
+10.36% | 9.49B | |
-9.33% | 2.11B | |
-1.93% | 1.43B | |
-2.14% | 1.17B | |
+122.40% | 1.02B | |
+5.90% | 525M | |
-23.66% | 387M | |
-6.67% | 229M | |
-2.70% | 221M |
- Stock Market
- Equities
- SAMPRE6 Stock
- Financials Sampre Nutritions Limited